Search Results | Grifols

Showing 548 search results

Filter by

Filter by

search_filters (Optional)

Contents

Files

News

search_filters-check

Sort by

Newest Oldest A-Z Z-A

Grifols fully refinances all 2027 maturities following a significantly upsized €3bn Term Loan B

April 1, 2026

Grifols prepares IPO of its US Biopharma business

March 24, 2026

Grifols shares results from its Chronos platform identifying early molecular changes associated with Parkinson’s disease

March 17, 2026

Grifols to double Revolving Credit Facility to $2 billion following strong support from global bank syndicate

March 16, 2026

Grifols and Ace Alzheimer Center Barcelona renew their collaboration to promote the AMBAR® clinical program and incorporate new centers

March 12, 2026

Grifols reports revenues of EUR 7,524m, up 7%, and more than doubles Group profit to EUR 402m

February 26, 2026

Grifols Welcomes Moody’s Ratings’ Upgrade to B1 with Stable Outlook

February 16, 2026

Grifols receives US FDA approval for new fibrinogen concentrate, FESILTY^TM (fibrinogen, human-chmt)

December 19, 2025

Grifols Welcomes S&P Global Ratings’ Upgrade to ‘BB-’ with Stable Outlook

December 17, 2025

Grifols obtains approval from the European Medicines Agency for the entire value chain of Grifols Egypt

December 16, 2025

Egypt achieves self-sufficiency in plasma-derived medicines thanks to Grifols

December 4, 2025

Grifols appoints Tomás Dagá as Vice President of the board of Grifols Egypt (GEPD) and accelerates plasma self-sufficiency for 2026

November 27, 2025

Show more results